Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Discovery of Etrumadenant, a First-in-class Dual A2a and A2b Adenosine Receptor Antagonist for Cancer Immunotherapy

Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Joel Beatty,Jenna L. Jeffrey,Laurent P. P. Debien,Rhiannon Thomas-Tran,Debashis Mandal, Dan Direnzo,Sachie Marubayashi,Kristen Zhang,Ferdie Soriano,Elaine Ginn,Divyank Soni, Pei-Yu Chen,Lixia Jin,Steve W. Young,Matt J. Walters,Manmohan R. Leleti,Jay P. Powers

MOLECULAR CANCER THERAPEUTICS（2024）

Cited 0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined